Patient-Derived Xenograft Market Forecast 2024

добавлена новая статья Networking

2026-02-20 04:29:25 -

Patient-Derived Xenograft Market Forecast 2024–2034

Market Overview The Patient-Derived Xenograft (PDX) Model Market is emerging as a cornerstone of modern oncology research, driven by the growing need for translational models that closely replicate human tumor biology. The market is anticipated to expand from USD 363.7 million in 2025 to USD 1,121.9 million by 2035, reflecting a robust CAGR of approximately 12.1% over the forecast period. This...

0 Комментарии 0 Поделились 66 Просмотры 0 предпросмотр